.png){kind=icon}
返回
Malaria
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(13)60024-0.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Although global morbidity and mortality have decreased substantially, malaria, a parasite infection of red blood cells, still kills roughly 2000 people per day, most of whom are children in Africa. Two factors largely account for these decreases; increased deployment of insecticide-treated bednets and increased availability of highly effective artemisinin combination treatments. In large trials, parenteral artesunate (an artemisinin derivative) reduced severe malaria mortality by 22.5% in Africa and 34.7% in Asia compared with quinine, whereas adjunctive interventions have been uniformly unsuccessful. Rapid tests have been an important addition to microscopy for malaria diagnosis. Chemopreventive strategies have been increasingly deployed in Africa, notably intermittent sulfadoxine-pyrimethamine treatment in pregnancy, and monthly amodiaquine-sulfadoxine-pyrimethamine during the rainy season months in children aged between 3 months and 5 years across the sub-Sahel. Enthusiasm for malaria elimination has resurfaced. This ambitious but laudable goal faces many challenges, including the worldwide economic downturn, difficulties in elimination of vivax malaria, development of pyrethroid resistance in some anopheline mosquitoes, and the emergence of artemisinin resistance in Plasmodium falciparum in southeast Asia. We review the epidemiology, clinical features, pathology, prevention, and treatment of malaria.
Keyword:
PLASMODIUM-FALCIPARUM MALARIA
HUMAN CEREBRAL MALARIA
VON-WILLEBRAND-FACTOR
ACUTE-RENAL-FAILURE
VIVAX MALARIA
AFRICAN CHILDREN
ARTEMETHER-LUMEFANTRINE
PYRONARIDINE-ARTESUNATE
INFECTED ERYTHROCYTES
INTRACRANIAL-PRESSURE
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
分享收藏Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis
OAAI
OAAI分享收藏Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.png)
LANCET
LANCETIF88.5
PREAI
分享收藏
查看更多内容